Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Immunity|September 4, 2004
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiationA L Shaffer, Miriam Shapiro-Shelef, Neal N Iwakoshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigensRyan M Young, Tianyi Wu, Roland Schmitz, et al.
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaMichael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Immunity|September 4, 2004
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiationA L Shaffer, Miriam Shapiro-Shelef, Neal N Iwakoshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigensRyan M Young, Tianyi Wu, Roland Schmitz, et al.
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaMichael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Pageof 29